PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction

Completed · Not applicable

Conditions studied: Macromastia

In brief

The objective of this clinical study is to evaluate the operative performance of the PEAK PlasmaBlade 4.0 during bilateral breast reduction; to monitor and record post-operative pain, adverse events and skin scarring following surgery; and compare these outcomes to the current standard of care (SOC).

Key facts

Study ID
NCT00986453
Run by
Medtronic Surgical Technologies
People needed
45
Starts
2010-01-01
Expected to finish
2011-09-01
Last updated by the study team
2013-01-01

Who can join

Age: 20 and older, up to 60. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.